Insight Molecular Diagnostics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 11/16/2026 | 12.68 M | $45.54 M | 0.00% | 34.52% |
| AWM INVESTMENT COMPANY, INC. | 11/13/2026 | 2.77 M | $9.95 M | -2.29% | 7.54% |
| VANGUARD CAPITAL MANAGEMENT LLC | 11/13/2026 | 731.39 K | $2.63 M | -0.61% | 1.99% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/06/2026 | 270.56 K | $972.06 K | 5.32% | 0.74% |
| TWO SIGMA INVESTMENTS, LP | 11/16/2026 | 201.91 K | $724.87 K | 1,718.88% | 0.55% |
| VANGUARD FIDUCIARY TRUST CO | 11/13/2026 | 150.92 K | $541.80 K | 21.15% | 0.41% |
| BLACKROCK, INC. | 11/13/2026 | 148.53 K | $533.21 K | -1.33% | 0.40% |
| STATE STREET CORP | 11/12/2026 | 121.62 K | $436.63 K | 32.02% | 0.33% |
| WALLEYE CAPITAL LLC | 11/13/2026 | 57.59 K | $206.74 K | 100.00% | 0.16% |
| NORTHERN TRUST CORP | 11/16/2026 | 53.29 K | $191.30 K | 8.55% | 0.15% |
| UBS GROUP AG | 11/10/2026 | 44.87 K | $161.09 K | -15.77% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/16/2026 | 44.04 K | $158.11 K | 100.00% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/16/2026 | 39.20 K | $140.73 K | 100.00% | 0.11% |
| OSAIC HOLDINGS, INC. | 11/12/2026 | 39.14 K | $140.47 K | 0.00% | 0.11% |
| BANK OF AMERICA CORP /DE/ | 11/16/2026 | 37.21 K | $133.60 K | 100.00% | 0.10% |
| JANE STREET GROUP, LLC | 11/12/2026 | 36.08 K | $129.53 K | -77.12% | 0.10% |
| JUMP FINANCIAL, LLC | 11/13/2026 | 35.40 K | $127.09 K | 100.00% | 0.10% |
| CITADEL ADVISORS LLC | 11/16/2026 | 33.51 K | $120.30 K | 100.00% | 0.09% |
| MARSHALL WACE, LLP | 11/13/2026 | 22.83 K | $81.96 K | 37.56% | 0.06% |
| GSA CAPITAL PARTNERS LLP | 11/16/2026 | 19.25 K | $69.00 K | 100.00% | 0.05% |
| JEFFERIES FINANCIAL GROUP INC. | 11/05/2026 | 18.10 K | $64.98 K | 0.00% | 0.05% |
| MORGAN STANLEY | 11/13/2026 | 17.54 K | $62.98 K | -50.60% | 0.05% |
| SAVVY ADVISORS, INC. | 11/12/2026 | 15.00 K | $53.85 K | 100.00% | 0.04% |
| FLATROCK WEALTH PARTNERS LLC | 11/12/2026 | 14.30 K | $51.34 K | 9.63% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 11/13/2026 | 12.92 K | $46.38 K | 123.69% | 0.04% |
| CERITY PARTNERS LLC | 11/13/2026 | 11.95 K | $42.89 K | 100.00% | 0.03% |
| PRIVATE ADVISOR GROUP, LLC | 11/10/2026 | 10.42 K | $37.39 K | 0.00% | 0.03% |
| SMITH, MOORE & CO. | 11/12/2026 | 10.00 K | $35.90 K | 100.00% | 0.03% |
| BNP PARIBAS FINANCIAL MARKETS | 11/12/2026 | 9.54 K | $34.25 K | 64.45% | 0.03% |
| EVERSOURCE WEALTH ADVISORS, LLC | 11/04/2026 | 5.00 K | $17.95 K | 0.00% | 0.01% |
| TRANSCE3ND, LLC | 10/26/2026 | 1.00 K | $3.02 K | 100.00% | 0.00% |
| BARCLAYS PLC | 11/06/2026 | 584 | $2.10 K | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/16/2026 | 501 | $2.00 K | 99.60% | 0.00% |
| JPMORGAN CHASE & CO | 11/12/2026 | 309 | $1.05 K | 100.65% | 0.00% |
| ASCENTIS INDEPENDENT ADVISORS | 11/03/2026 | 100 | $359 | 100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 11/13/2026 | 63 | $247 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 10/29/2026 | 39 | $140 | -13.33% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/16/2026 | 7 | $25 | 0.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 11/16/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/16/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/16/2026 | 0 | $0 | -100.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 11/13/2026 | 0 | $0 | -100.00% | 0.00% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/16/2026 | 0 | $0 | -100.00% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 11/10/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 11/16/2026 | 0 | $0 | -100.00% | 0.00% |
| AXQ CAPITAL, LP | 11/12/2026 | 0 | $0 | -100.00% | 0.00% |
| CASSADAY & CO WEALTH MANAGEMENT LLC | 10/27/2026 | 0 | $0 | -100.00% | 0.00% |
Insight Molecular Diagnostics Inc. institutional Ownership - FAQ's
During the previous two years, 50 institutional investors and hedge funds held shares of Insight Molecular Diagnostics Inc.. The most heavily invested institutionals were:
BROADWOOD CAPITAL INC: 12.68 M
AWM Investment Company, Inc.: 2.77 M
VANGUARD CAPITAL MANAGEMENT LLC: 731,391
GEODE CAPITAL MANAGEMENT, LLC: 270,558
TWO SIGMA INVESTMENTS, LP: 201,914
VANGUARD FIDUCIARY TRUST CO: 150,918
47.98% of Insight Molecular Diagnostics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.72 M shares in the last 24 months. This purchase volume represents approximately $36.69 M in transactions.